Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

NCT01007448

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Florida Academic Dermatology Centers Miami, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Rush University Chicago, Illinois, United States
View all 17 locations
View Trial Details
Completed

A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma

NCT01169298

Conditions
Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • National Kyusyu Cancer Center Fukuoka, Japan
  • Imamura Bun-in Hospital Kagoshima, Japan
  • Kumamoto University Hospital Kumamoto, Japan
  • Nagasaki University Hospital Nagasaki, Japan
View Trial Details
Completed

A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)

NCT00106431

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • UCLA Jonsson Cancer Center Los Angeles, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • University of Pennsylvania Abrahamson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00105001

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +173 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
View Trial Details
Completed

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

NCT02243579

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +19 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Yale University New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

NCT00005799

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +105 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • University of Colorado Denver, Colorado, United States
  • Baylor University Medical Center Dallas, Texas, United States
View Trial Details

Related conditions